To elucidate clinicopathologic manifestations of cutaneous lymphoproliferative disorders associated with Epstein-Barr virus (EBV) infection.
Retrospective survey of case series.
University hospital medical center.
Sixty-five patients with cutaneous lymphomas and related disorders.
Main Outcome Measures:
Detection of EBV genes and EBV-encoded small nuclear RNAs.
Evidence of latent EBV infection was demonstrated in 15 patients: 3 had malignant lymphoma with clinical features mimicking cytophagic histiocytic panniculitis, 6 had facial vesiculopapular eruptions mimicking hydroa vacciniforme, 4 had angiocentric lymphoma, I had histiocytoid lymphoma associated with hemophagocytosis, and I had plasmacytoma. Hypersensitivity to mosquito bites was noted in a patient with hydroa vacciniforme-like eruptions and another with histiocytoid lymphoma. Angiocentric infiltration of atypical lymphoid cells was a common histological feature in the patients with hydroa vacciniforme-like eruptions and angiocentric lymphoma. No evidence of EBV infection was apparent in 19 patients with mycosis fungoides or Sézary syndrome, 7 with adult T-cell leukemia or lymphoma, 3 with lymphomatoid papulosis (type A), and 2 with lymphocytoma cutis.
Patients with EBV-associated cutaneous lymphoproliferative disorders present with unique and diagnostic clinicopathologic features distinct from those of mycosis fungoides or Sézary syndrome.Arch Dermatol. 1997;133:1081-1086
Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. Clinicopathologic Manifestations of Epstein-Barr Virus—Associated Cutaneous Lymphoproliferative Disorders. Arch Dermatol. 1997;133(9):1081–1086. doi:10.1001/archderm.1997.03890450023003
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: